FemPulse Corporation
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, FemPulse Corporation sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
FemPulse Corporation: 6 sponsored US clinical trials, 1 recruiting.
FemPulse Corporation sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Overactive Bladder (OAB), with 1 trials.
Upper-quartile sponsor footprint
FemPulse Corporation sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
NCT07195656
Ease of Use Study of the FemPulse System
NCT06885099
Usability Study of the FemPulse System
NCT06347380
Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device
NCT04001426
FemPulse Therapy for Overactive Bladder in Women
NCT03784170
FemPulse Therapy First-in-Human Experience
NCT03874637
Therapeutic Areas
What is open in the FemPulse Corporation pipeline
1 recruiting of 6 indexed (17% open); 5 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Overactive Bladder (OAB) (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
FemPulse Corporation: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
FemPulse Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this FemPulse Corporation page
6 registered trials is a research-attention snapshot, not an endorsement of FemPulse Corporation or any single study.
- 1 of FemPulse Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Overactive Bladder (OAB) is the condition FemPulse Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Overactive Bladder (OAB) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
FemPulse Corporation pipeline card: 6 registered trials from official public datasets.Report a data error.